Candel's Stock Soars Following Encouraging Phase III Results for Prostate Cancer Treatment

Candel’s Stock Soars Following Encouraging Phase III Results for Prostate Cancer Treatment

Candel's Stock Soars Following Encouraging Phase III Results for Prostate Cancer Treatment